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Lrotecting the central nervous system during ischemia:
difficult taskohn A. Kern, MD
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226 The Journal of Thoracic and Cardhis issue contains a remarkable study by Kawata and colleagues.1 The
prevention of central nervous system (CNS) damage during prolonged hy-
pothermic circulatory arrest has significant ramifications. In this study the
uthors demonstrated that erythropoietin (EPO) crosses the blood brain barrier and
rotects the brain and spinal cord from prolonged ischemic injury during hypother-
ic circulatory arrest. The fact that the animals in this study were kept under
ypothermic circulatory arrest for 120 minutes is simply astounding. The use of
PO for CNS protection during cold ischemia is a novel concept. However, the
xact mechanism needs to be elucidated. Because EPO is already used in humans,
nd safety and efficacy data are already known, a clinical trial could be easily
stablished.
This study has limitations. Only 5 animals were used in each of the EPO and
ontrol groups. In addition, the animals were never fully allowed to recover and
ere always kept intubated and anesthetized during the recovery and neurologic
ssessment period. Even with the modification of the neurologic scoring system to
llow for this, I have grave reservations about how accurately the animals’ neuro-
ogic status could be evaluated. One cannot argue with the results of the histologic
nalyses and the evaluation of the brain, spinal cord, and cerebrospinal fluid, and it
eems as though EPO does have direct protective effects on the CNS. Whether these
eneficial effects are long-lasting needs to be elucidated through chronic studies.
lso, although many drugs have proven beneficial in protecting the brain and spinal
ord during ischemia in experimental animal models, none have proven particularly
eneficial in humans.
Although the results of this study are remarkable and give us reason to be excited,
e must temper our enthusiasm with the reality that this is but one study in a very
mall group of animals that were evaluated (while anesthetized and intubated) for
nly 12 hours postoperatively. Clearly, more work needs to be done.
eference
. Kawata M, Takamoto S, Kitahoi K, Tsukihara H, Morota T, Ono M, et al. Erythropoietin protects the
central nervous system during prolonged hypothermic circulatory arrest: An experimental study in a
canine model.
Notice of Retraction
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This article has been retracted by the Publisher.
Due to an administrative error in production, it was published twice—in the December 2005 issue
(J Thor Cardiovasc Surg 2005;130:1523-1530) and in the January 2006 issue (J Thor Cardiovasc Surg
2006;131:190-197). The article has been retracted from the January 2006 issue. The version of recordr 2005 issue (J Thor Cardiovasc Surg 2005;130:1523-1530).
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